Positive Sobriety Institute hosts and participates in a series of addiction-related health events and lectures. Through our events and lecture series, Dr. Dan Angres and other addiction experts present important topics on addiction. We invite you to attend upcoming discussions.
PSI Lunch and Learn Series, alcohol recovery
PSI Lunch and Learn Series
Our monthly Lunch and Learn presents the most recent advances in the treatment of substance use disorders. Events are held from 12:00-1:00 pm CT (time may vary, please review event detail), and a Q&A session follows from 1:00-1:30. Lunch is provided, and Continuing Education hours are offered. Events are held at Positive Sobriety Institute, 680 N. Lake Shore Drive Suite 800 Chicago.
Previous Events and Lectures
November 21, 2019:
An Overview of a Licensed Professional’s Potential Legal Liabilities as a Result of an Addiction presented by Joseph J. Bogdan, Pharm. D.,RPM, J.D
August 15, 2019:
Functional Neuroimaging of Addiction presented by Gene-Jack Wang, MD
February 28th, 2019: Introduction & Overview of Radically-Open Dialectical Behavior Therapy presented by Danielle Doucette, PsyD & Rose Metivier, LCPC, NCC
In this presentation, we will provide an overview of RO-DBT that will offer participants a basic understanding of RO-DBT, how the treatment benefits these specific presentations, and how it is implemented. VIEW PRESENTATION
November 29, 2018: What’s Addiction Got to Do with It? Understanding Eating Disorders within the Addiction Spectrum presented by Kimberly D. Dennis, MD, CEDS.
May 24, 2018: Self Transcendence in Addiction Recovery presented by Daniel H. Angres, MD.
April 24, 2018: A Tough Nut to Crack: Acceptance and Commitment Therapy presented by Stephen Reeder, MA, LPCC, NCC.
January 25, 2018: Understanding Sex Addiction Through an Attachment and Trauma Lens. Lisa Lackey, LCPC, CSAT, CMAT, EMDR II.
May 25, 2017: Marijuana: The New Big Tobacco? Lessons Learned from Legalization. Kevin A. Sabet, PhD.
March 30, 2017: Synthetic Cannabinoids: A Review. Lauren Pace, DO.
January 26, 2017: Internet Gaming Disorder: The Allure of the Virtual World. Anish John, MD
October 27, 2016: Managing Disruptive Behavior in Healthcare Professionals. Philip Hemphill, Ph.D
May 26, 2016: Continuing Care Issues for Recovering Professionals. Wally Cross, RPh, MHS, CADC
March 30, 2016: Dual Diagnosis: Chicken, Egg or Both? Mark S. Gold, MD, Chairman of RiverMend Health Scientific Advisory Board
December 5, 2015: Educating the GME Learning Community About Impairment; Residents must be active participants in their own wellness, but they require training and preparation to avoid the pitfalls of their fast-paced work environment – and other members of the GME community need training as well. Karen Broquet, MD and Dan Angres, MD.
June 12, 2015: “Healing the Healer” presented at the American Bar Association/Chicago Medical Society Physician Legal Issues Conference: Dr. Daniel Angres Presenting with book chapter in the published proceedings.
June 10, 2015: Overview on Detoxification: Presentation to NU hospitalists Dr. Daniel Angres
May 29, 2015: 1st Annual Symposium on Addiction “Marijuana, Medicine or Madness” Lombard Illinois. Illinois Professional Health Program, Advocate Behavioral Health, PSI/Dr. Daniel Angres, co-sponsors
May 20, 2015: Physician Impairment and Wellness, NU Forensic Psychiatry Fellows: Dr. Daniel Angres
May 13, 2015: Psychopharmacology of Cocaine, NU 2nd year psychiatry residents: Dr. Daniel Angres
May 11, 2015: PSI Special Presentation: “My Addiction Research Career from Clonidine, Naltrexone, Dopamine, Cocaine and Smoking to Gambling, Sex and Food”: Mark Gold M.D. 12:00 NOON.
May 6, 2015: Mentoring Meeting NU, Dr. Daniel Angres
April 29, 2015: Psychopharmacology of Opiates, NU 2nd year psychiatry residents: Dr. Daniel Angres
April 16, 2015: NU CME Internal Medicine “The Disease of Addiction” Dr. Daniel Angres
April 13, 2015: Published article in Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)”
“Treatment Strategies for Cannabis Use in Schizophrenia”
Brian R. Schultz, M.D., Ph.D1 Lisette Rodriguez-Cabezas, M.D1 Daniel Angres, M.D1,2 Matthew J. Smith, Ph.D1,3,*
April 6th-7th 2015:“Masters of Addiction” conference, Augusta Ga.” Dr. Daniel Angres et.al.
March 13th 2015: Open House and Keynote: “Marijuana and Opioid “Cross Talk”, Risks for the
Born, Unborn,” by Bertha Madras P.H.D., Professor of Psychobiology, Harvard
Medical School and Member, RiverMend Health Scientific Advisory Board.
March 11th 2015: NU Grand Rounds: NU 3rd year Residents: Overview of Addiction, inspired by 3rd year PSI rotations.
February 26th 2015: Joint NU and PSI Addiction Rounds: “The role of personality in addiction: Research and treatment implications” Phil Chow, Psychology Intern, Dr. Daniel Angres
February 10th 2015: Physician Wellness to Illinois Masonic Medical Staff: Dr. Daniel Angres
February 4th 2015: Psychopharmacology of Alcoholism to NU 3rd year psychiatry residents: Dr. Daniel Angres
This presentation will discuss the current epidemiology of alcohol use in pregnancy and challenges in risk stratification and current recommendations for acceptable levels of alcohol consumption during pregnancy. We will also discuss the pathophysiology and clinical presentation of fetal alcohol syndrome (FAS) and analyze techniques for prevention and potential treatment options.
Synthetic Cannabinoids (SCs) have become widely abused as recreational drugs, and are now known to carry a risk of severe mental and physical health effects. SCs mimic the psychoactive effects of cannabis and have been recognized as drugs of abuse since 2008. However, SCs differ structurally from cannabis, which may explain the emergence of severe psychiatric symptoms following SC ingestion. This presentation examines catatonia occurring in the context of SC use in two patients with no prior history of psychosis. Pharmacological management in the context of SC induced catatonia is also discussed, as well as long term sequelae of heavy synthetic cannabinoid use.
At a time when health care is shifting toward the prevention, identification and long-term monitoring of chronic serious illnesses, now is the time for substance use disorders to be treated like other chronic illnesses. Today all treatment for substance use disorders is episodic while addiction poses a life-long threat to health. The physician health program (PHP) system of care management takes a long-term, comprehensive approach to substance use disorders to produce the best long-term outcomes for addiction. The elements of the PHP model will be presented along with outcomes from a national study of 16 PHPs. The PHPs are a part of a New Paradigm for long-term recovery which extends beyond the population health care professionals. A conceptual model for maximizing five-year recovery rates in other addicted populations is presented.
For professionals completing treatment, meticulous and appropriate continuing care recommendations can be critical to long term successful outcomes. Care should be taken to begin planning for continuing care issues reasonably early and throughout the course of a professionals’ treatment.
In our society, a number of threats to physician well-being and a culture of safety exist and must be addressed in physician wellness programs. These include substance use disorders, mood disorders, anxiety disorders, sexual boundary violations, disruptive physicians, personality disorders, misprescribing drugs and cognitive impairment.
A growing and converging body of literature is establishing the empirical association between disruptive behavior and safety/quality. Leape and Fromme (2006) based upon a review of studies estimate the prevalence of disruptive behavior to range between 3-5%. Rosenstein and O’Daniel (2008) recommend three broad approaches to address disruptive behavior including prevention, addressing it when it occurs in real-time, and dealing with it after a particular incident or series of incidents occur. The focus of this session will be how to deal with disruptive behavior after it takes place. This focus does not dismiss the importance of prevention and other efforts. Yet, it will describe the individuals responsible for disruptive behavior and the numerous direct and indirect costs associated with their behavior.
In this presentation, Dr. Sabet provides an overview of the current drug policy trends in the United States and debunks some of the most cited myths about marijuana use. For instance, marijuana is harmless and non-addictive, and legalization will solve the government’s budgetary problems. Dr. Sabet makes the claim that our greatest concern should be the inevitable rise of a second Big Tobacco industry, this time marketing marijuana to our children and youth. He refers to the already arising problems in Colorado and Washington as examples.
Concussion has become the hottest topic in sports and military medicine over the past decade. The impact of repetitive concussions has been linked to suicidal behavior and significant long-term neurocognitive and psychiatric abnormalities in athletes competing in contact sports and military personnel. Recent advanced neuroimaging studies have provided evidence of white matter abnormalities associated with multiple concussions. Although virtually all of the extant literature focuses on this unique population, other patient populations are at risk for undiagnosed multiple concussions. These include the elderly, victims of domestic violence, and patients with substance use disorders. This presentation reviews the current knowledge on concussion and its potential impact on the diagnosis and treatment of a patient suffering from substance use disorders.
It is well known that the rates of alcohol and substance use disorders are higher in men than women. The gender gap, however, has been narrowing consistently in the recent decades, especially among the younger generations. Women have been noted to have a faster disease progression compared to men, differing patterns of comorbid psychiatric disorders including a higher prevalence of trauma and mood disorders, and unique needs when it comes to treatment. This presentation examines the epidemiology, etiology, treatment outcomes as well risk factors specific to women in order to better understand this growing problem. Substance use in pregnant women, its neonatal effects and treatment options is also discussed in brief.
Sexual addiction is an intimacy disorder that can be the outcome of impaired early attachment experiences and childhood trauma. This dysregulated bonding and unresolved trauma causes shame in the developing child. Primary needs and desires become unmet to the individual. Affect regulation also is damaged because of difficult bonding experiences. This further impairs the capacity to master feelings and successfully guide the process of need fulfillment and social engagement. Sexual addiction is a compulsive cycle that attempts to compensate, soothe, and regulate the internal struggle. The cycle, in turn, creates more shame and dysregulation of affect. This presentation outlines strategies to reduce shame, regulate affect, and create sexual boundaries necessary for successful treatment of sexual addiction.